{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T18:59:31Z","timestamp":1792004371881,"version":"4.4.0"},"reference-count":15,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100005918","name":"Christian Medical College Vellore","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005918","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Indian Journal of Medical Microbiology"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.ijmmb.2026.101146","type":"journal-article","created":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T04:03:39Z","timestamp":1778817819000},"page":"101146","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Can aztreonam\/avibactam combined with fosfomycin be a treatment option for infections caused by NDM-producing Pseudomonas aeruginosa?"],"prefix":"10.1016","volume":"62","author":[{"given":"Rosemol","family":"Nelson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yamuna Devi","family":"Bakthavatchalam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binesh Lal","family":"Yesudason","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuvasri","family":"Manokaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baby Abirami","family":"Shankar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sangeetha","family":"Nithya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajiv","family":"Karthik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Balaji","family":"Veeraraghavan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijmmb.2026.101146_bib1","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1128\/AAC.45.2.480-484.2001","article-title":"Carbapenem resistance mechanisms in Pseudomonas aeruginosa clinical isolates","volume":"45","author":"Pai","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijmmb.2026.101146_bib2","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1080\/22221751.2022.2048972","article-title":"Carbapenemase-producing Pseudomonas aeruginosa an emerging challenge","volume":"11","author":"Tenover","year":"2022","journal-title":"Emerg Microb Infect"},{"key":"10.1016\/j.ijmmb.2026.101146_bib3","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3947\/ic.2015.47.2.81","article-title":"Epidemiology and characteristics of metallo-\u03b2-lactamase-producing Pseudomonas aeruginosa","volume":"47","author":"Hong","year":"2015","journal-title":"Infect Chemother"},{"key":"10.1016\/j.ijmmb.2026.101146_bib4","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jinf.2023.04.013","article-title":"Poor in vitro activity of ceftazidime\/avibactam, ceftolozane\/tazobactam, and meropenem\/vaborbactam against carbapenem-resistant Pseudomonas aeruginosa in India: results from the Antimicrobial Testing Leadership and Surveillance (ATLAS) program, 2018-2021","volume":"87","author":"Lee","year":"2023","journal-title":"J Infect"},{"key":"10.1016\/j.ijmmb.2026.101146_bib5","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01582-20","article-title":"In vitro activity of cefiderocol, a siderophore cephalosporin, against multidrug-resistant Gram-negative bacteria","volume":"64","author":"Mushtaq","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijmmb.2026.101146_bib6","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciae403","article-title":"Infectious Diseases Society of America 2024 guidance on the treatment of antimicrobial-resistant gram negative infections","author":"Tamma","year":"2024","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijmmb.2026.101146_bib7","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ijmmb.2021.12.006","article-title":"Susceptibility testing for aztreonam plus ceftazidime\/avibactam combination: a general guidance for clinical microbiology laboratories in India","volume":"40","author":"Bakthavatchalam","year":"2022","journal-title":"Indian J Med Microbiol"},{"key":"10.1016\/j.ijmmb.2026.101146_bib8","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1093\/jac\/dkae253","article-title":"Combination therapy with IV fosfomycin for adult patients with serious Gram-negative infections: a review of the literature","volume":"79","author":"Butler","year":"2024","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijmmb.2026.101146_bib9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0256308","article-title":"Emergence of blaNDM-1 and blaVIM producing Gram-negative bacilli in ventilator-associated pneumonia at AMR Surveillance Regional Reference Laboratory in India","volume":"16","author":"Kumari","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.ijmmb.2026.101146_bib10","series-title":"Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically: M07-A11","author":"Weinstein","year":"2018"},{"key":"10.1016\/j.ijmmb.2026.101146_bib11","series-title":"Methods for determining bactericidal activity of antimicrobial agents: approved guideline","author":"Barry","year":"1999"},{"key":"10.1016\/j.ijmmb.2026.101146_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2024.107249","article-title":"Novel \u03b2-lactam\/\u03b2-lactamase inhibitor combinations show limited activity against Indian carbapenem-resistant Pseudomonas aeruginosa isolates due to conundrum of diverse resistance mechanisms","volume":"64","author":"Joshi","year":"2024","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijmmb.2026.101146_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2023.107035","article-title":"Battle of polymyxin induced nephrotoxicity: polymyxin B versus colistin","volume":"63","author":"Ball\u0131","year":"2024","journal-title":"Int J Antimicrob Agents"},{"issue":"2","key":"10.1016\/j.ijmmb.2026.101146_bib14","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.diagmicrobio.2019.05.014","article-title":"In vitro investigation of synergy among fosfomycin and parenteral antimicrobials against carbapenemase-producing Enterobacteriaceae","volume":"95","author":"Avery","year":"2019","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.ijmmb.2026.101146_bib15","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1592\/phco.23.7.916.32722","article-title":"The role of multidrug efflux pumps in the antibiotic resistance of Pseudomonas aeruginosa and other gram-negative bacteria. Insights from the Society of Infectious Diseases Pharmacists","volume":"23","author":"Aeschlimann","year":"2003","journal-title":"Pharmacotherapy"}],"container-title":["Indian Journal of Medical Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0255085726001040?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0255085726001040?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T08:28:25Z","timestamp":1787128105000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0255085726001040"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":15,"alternative-id":["S0255085726001040"],"URL":"https:\/\/doi.org\/10.1016\/j.ijmmb.2026.101146","relation":{},"ISSN":["0255-0857"],"issn-type":[{"value":"0255-0857","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Can aztreonam\/avibactam combined with fosfomycin be a treatment option for infections caused by NDM-producing Pseudomonas aeruginosa?","name":"articletitle","label":"Article Title"},{"value":"Indian Journal of Medical Microbiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijmmb.2026.101146","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Indian Association of Medical Microbiologists. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"101146"}}